101583-3

ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture Qualitative

Active

Part Descriptions

LP232452-5 Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio
Extended spectrum beta-lactamase (ESBL) enzymes are resistance enzymes produced by pathogenic organisms such as E. coli and Klebsiella. The presence of ESBLs can be detected by comparing the inhibitory concentration (IC) of a specific antimicrobial, such as cefepime (a 4th generation cephalosporin), cefotaxime, or ceftazidime (both 3rd generation cephalosporins), with the IC of that antimicrobial plus clavulanate, an ESBL inhibitor. Source: Regenstrief LOINC

LP426925-6 Based on lab data
The method "Based on lab data" is intended to be used when a series or combination of laboratory results are utilized together to arrive at a subsequent single result. Source: Regenstrief LOINC

LOINC Names Get Info

Fully-Specified Name: Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio:Imp:Pt:Bld.pos growth:Ord:Based on lab data
Long Common Name: ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture Qualitative
Short Name: ESBL cft to cft-clav IC rto Bd Pos Imp
Display Name: ESBL by ceftazidime to ceftazidime-clavulanate IC ratio based on lab data Ql (Pos bld culture) [Interp]
Consumer Name Alpha Get Info: ESBL by ceftazidime to ceftazidime-clavulanate IC Ratio, Infected blood

Part Model Get Info

Component
Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio
LP232452-5
- Analyte
  Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio
  LP232452-5
  - Component Numerator
    Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio
    LP232452-5
    - Component Numerator Core
      Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio
      LP232452-5
    - Component Numerator Core Suffix
      NULL
  - Component Denominator
    NULL
    - Component Denominator Core
      NULL
    - Component Denominator Core Suffix
      NULL
- Challenge
  NULL
- Adjustment
  NULL
- Count
  NULL
Property
Imp
LP6819-9
Time
Pt
LP6960-1
- Time Core
  Pt
  LP6960-1
- Time Modifier
  NULL
System
Bld.pos growth
LP183539-8
- System Core
  Bld.pos growth
  LP183539-8
- Super System
  NULL
Scale
Ord
LP7751-3
Method
Based on lab data
LP426925-6

Example Answer List: LL744-4

Source: Regenstrief Institute

Answer	Code	Score	Answer ID
Detected			LA11882-0
Not detected			LA11883-8

Basic Attributes

Class: ABXBACT
Type: Laboratory
First Released: Version 2.75
Last Updated: Version 2.75 (ADD)
Order vs. Observation: Both

Language Variants Get Info

Tag	Language	Translation
cs-CZ	Czech (Czechia)	ESBL pomocí poměru inhibiční koncentrace ceftazidimu k ceftazidim-klavulanátu:Interpretace:Časový bod:Krev pozitivní kultivace:Ordinální:Na základě laboratorních dat
el-GR	Greek (Greece)	Αναλογία ανασταλτικής συγκέντρωσης β-λακταμάσης εκτεταμένου φάσματος από κεφταζιδίμη προς κεφταζιδίμη+κλαβουλανικό:Imp:Pt:Αίμα.θετική ανάπτυξη:Ord:Με βάση τα εργαστηριακά δεδομένα Synonyms: ABXBACT Imp Kλαβουλανικό Ord Pt Αίμα Αίμα.θετική ανάπτυξη Αναλογία ανασταλτικής συγκέντρωσης β-λακταμάσης εκτεταμένου φάσματος από κεφταζιδίμη προς κεφταζιδίμη+κλαβουλανικό Βήτα λακταμάση Κεφταζιδίμη Κεφταζιδίμη+Kλαβουλανικό Με βάση τα εργαστηριακά δεδομένα
es-ES	Spanish (Spain)	ESBL para la concentración inhibitoria de ceftazidima frente a la de ceftzidima-clavulanico:Impresión/interpretación del estudio:Punto temporal:Sangre crecimiento positivo:Ord:Basado en datos de laboratorio
fr-FR	French (France)	Ratio CMI bêta lactamase à spectre élargi ceftazidime/ceftazidime+clavulanate:Interprétation:Ponctuel:Hémoculture positive:Qualitatif:Basé sur les données de laboratoire
it-IT	Italian (Italy)	Rapporto della concentrazione inibitoria di ceftazidime/ceftazidime e acido clavulanico, beta-lattamici a largo spettro:Imp:Pt:Emocolture positive:Ord:Basato su dati di laboratorio Synonyms: Impressione/interpretazione di studio Punto nel tempo (episodio) Rapporto della IC di ceftazidime/ceftazidime e aci Sangue Suscettibilità agli antibiotici
zh-CN	Chinese (China)	头孢他啶相对于头孢他啶+克拉维酸抑菌浓度比值法超广谱 beta 内酰胺酶:印象:时间点:血液.生长阳性:序数型:基于实验室数据 Synonyms: B Betalactamase Beta-内酰胺酶 B-Lactamase B-内酰胺酶 β β内酰胺酶 β-内酰胺酶 β-内酰胺酶抑制剂;棒酸依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型印象是一种诊断陈述，始终是对其他某种观察指标的解释或抽象（一系列检验项目结果、一幅图像或者整个某位病人），而且几乎总是由某位专业人员产生。;检查印象;检查印象/解释;检查的印象/解释;检查解释;解释;阐释基于（依据的是、根据、根据的是）实验室（实验室检验、检验、化验）数据头孢他啶（头孢噻甲羧肟、头孢他定、头孢塔齐定、头孢羧甲噻肟、头孢齐定、凯复定、凯福定、复达欣、噻甲羧肟头孢菌素）+克拉维酸（棒酸）头孢他啶（头孢噻甲羧肟、头孢他定、头孢塔齐定、头孢羧甲噻肟、头孢齐定、凯复定、凯福定、复达欣、噻甲羧肟头孢菌素）相对于（与、相对）头孢他啶（头孢噻甲羧肟、头孢他定、头孢塔齐定、头孢羧甲噻肟、头孢齐定、凯复定、凯福定、复达欣、噻甲羧肟头孢菌素）+克拉维酸（棒酸）抑菌浓度（抑制浓度、IC）比值（比例、比、比率）法超广谱 beta 内酰胺酶（超广谱β内酰胺酶、超广谱β-内酰胺酶、ESBL）;头孢他啶相对于头孢他啶+克拉维酸抑菌浓度比值法 ESBL 头孢噻甲羧肟;头孢他定;头孢塔齐定;头孢羧甲噻肟;头孢齐定;凯复定;凯福定;复达欣;噻甲羧肟头孢菌素抗生素敏感性试验;药敏;药敏类;药敏试验;药敏试验类时刻;随机;随意;瞬间血;血液血液.阳性生长;血培养阳性;阳性血培养;阳性血液培养;全血.生长阳性贝塔

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=101583-3

LOINC Copyright

Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.